Hypoxia-inducible factor-1alpha polymorphisms associated with enhanced transactivation capacity, implying clinical significance.
暂无分享,去创建一个
L. Poellinger | K. Tanimoto | N. Oue | W. Yasui | M. Nishiyama | K. Nakachi | T. Kumazaki | H. Eguchi | K. Yoshiga | K. Imai | K. Ukon | M. Kaneyasu